תאריך: 23/11/2017 - 25/11/2017
Chairpersons: Hilla Knobler and Zemin Yao
Is Reducing Triglyceride Levels a New Therapeutic Target?
Is Reducing Triglyceride Levels a New Therapeutic Target?Rafael Bitzur
Sheba Medical Center, Israel
A Gain-of-Function Variant of Human Apoc3 Associated with Hypertriglyceridemia
A Gain-of-Function Variant of Human Apoc3 Associated with HypertriglyceridemiaYao Zemin
University of Ottawa, Canada
Reducing De Novo Lipogenesis and Liver Fat by Fructose Restriction
Reducing De Novo Lipogenesis and Liver Fat by Fructose RestrictionAlejandro Gugliucci
Touro University-California, USA
The Chemokine CCL24 at the Crossroads of Atherosclerosis and Non Alchoholic Steatohepatitis
The Chemokine CCL24 at the Crossroads of Atherosclerosis and Non Alchoholic SteatohepatitisDan Haberman
Kaplan Medical Center, Israel
